Adipotide (Ftpp) — reference
A proapoptotic peptide designed to target the blood supply of white adipose tissue.
Regulatory status
Not FDA-Approved. Never approved; development did not proceed to general human use.
Reported cautions
Pharmacokinetics
No published human PK data — primate/rodent studies only. Notably, primate trial data raised kidney-safety concerns; worth a stronger caution note generally, separate from half-life.
This figure is tagged Not characterised in our evidence system. No reliable human pharmacokinetic data was found for this compound. We publish that fact rather than a number borrowed from an unreliable source. Any estimated curve here would be fiction, and should be treated as such. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.
Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →
What Peptide Plug does and does not publish
This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.
Frequently asked
Is Adipotide (Ftpp) FDA-approved?
What is the half-life of Adipotide (Ftpp)?
How reliable is that half-life figure?
What cautions are associated with Adipotide (Ftpp)?
Does Peptide Plug publish dosing for Adipotide (Ftpp)?
Does Peptide Plug sell Adipotide (Ftpp)?
Related tools
Free, no account required.